FREQUENCY OF CEFTRIAXONE RESISTANCE IN PATIENTS WITH E. COLI-INDUCED UTI PRESENTING TO KHYBER TEACHING HOSPITAL PESHAWAR

Main Article Content

Asif Khan
Kamran Saeed
Suleman Khan
Zeeshan ahmad
Saad Ali
Nasir Uddin

Keywords

ceftriaxone resistance, E. Coli-induced, UTI.

Abstract

UTIs are the second most common bacterial infection affecting individuals of different ages worldwide. Globally, an estimated 50% of women have UTIs at least once in their lifetime and UTIs are particularly more common in those aged 16–64 years. Since varying frequencies are determined by various available studies in different regions of the globe for prevalence of ceftriaxone resistance in E. Coli-induced UTIs, so I designed this study for determiningfrequency of ceftriaxone resistance in E. Coli-induced UTIs in patients admitted to our department.


OBJECTIVE: To determine the frequency of ceftriaxone resistance in patients with E. Coli-induced UTI presenting to Khyber Teaching Hospital Peshawar


Study Setting: Department of Medicine, Khyber Teaching Hospital, Peshawar.


Study Design: Descriptive study


Study Duration:  6 months 24/4/2022 to 24/10/2022.


MATERIAL AND METHOD: Mid-stream urine was taken in a sterile container. Urine routine examination to see for any pus cells and in case of urine positive for pus cells, it was sent for culture sensitivity.0.01 ml of urine sample was put on MacConkey and blood agar media through calibrated loop and incubated aerobically for 24 hours at 37°C. The plates showing significant growth as per Kass counts were processed further. Identification of isolated E. Coli was confirmed by colony characteristics, gram-staining andbio chemical analysis. E. coli growth detected was checked for ceftriaxone resistance and sensitivities. The treatment of all the patients were continued in the during culture and sensitivity results as per general ward guidelines. Ceftriaxone resistance was seen for in all included cases.


RESULTS: Our study shows that among 193 patients mean age was 35 years with SD ± 16.02. 69(36%) patients were male and 124(64%) patients were female. More over Ceftriaxone was resistant in 81(42%) patients and was not resistant in 112(58%) patients. 


CONCLUSION: Our study concludes the frequency of ceftriaxone resistance was 42% in patients with E. Coli-induced UTI presenting to Khyber Teaching Hospital Peshawar

Abstract 49 | PDF Downloads 16

References

1. Najafabadi MP, Dagoohian A, Rajaie S, Esfahani SHZ, Edalati M. Common microbial causes of significant bacteriuria and their antibiotic resistance pattern in the Isfahan province of Iran. J Chemother. 2018;30 (2018):348-53.
2. Muhammad A, Khan SN, Ali1 N, Rehman MU, Ali I. Prevalence and antibiotic susceptibility pattern of uropathogens in outpatients at a tertiary care hospital. New Microb New Infec. 2020;36:100716.
3. Mortazavi-Tabatabaei S, Ghaderkhani J, Nazari A, Sayehmiri K, Sayehmiri F, Pakzad I. Pattern of antibacterial resistance in urinary tract infections: a systematic review and meta-analysis. Int J Prev Med. 2019;10:169.
4. Waller TA, Pantin SAL, Yenior AL, Pujalte GGA. Urinary tract infection antibiotic resistance in the United States. Prim Care ClinOffPract. 2018;45(3):455-66.
5. Hossain A, Hossain SA, Fatema AN, Wahab A, Alam MM, Islame MN et al. Age and gender-specific antibiotic resistance patterns among Bangladeshi patients with urinary tract infection caused by Escherichia coli. Heliyon. 2020;6(6):04161.
6. Chua KYL, Stewardson AJ. Individual and community predictors of urinary ceftriaxone-resistant Escherichia coli isolates, Victoria, Australia. Antimicrob Resist Infect Control. 2019;8(36).
7. Ullah U, Javed K, Khan MA, Ullah I, Iman NU. Prevalence, distribution and determinants of Escherichia coli resistance to ceftriaxone in adult indoor UTI population of District Peshawar, Pakistan. Gomal J Med Sci 2020;18(2):45-53.
8. Prakash D, Saxena RS. Distribution and antimicrobialsusceptibility pattern of bacterialpathogens causing urinary tract infection inurban community of Meerut City, India. ISRNMicrobiol. 2013;2013:749629.
9. Sabir S, Anjum AA, Ijaz T, Ali MA, Khan MR, Nawaz M. Isolation and antibiotic susceptibility of E. coli from urinary tract infections in a tertiary care hospital. Pak J Med Sci. 2014;30(2):389-92
10. Lee WL, Harrison. RE, Grinstein S. Phagocytosis by neutro phils. Microbes infect 2003;5(14):1299-306
11. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia Coli. Nat Rev Microbiol 2004;2(2):123-40
12. Ohman L, Normann B, Stendahl O. Physicochemical surface properties of Escherichia Coli Strains isolated from different types of urinary tract infections. Infect immun 1981;32(2):951-5.
13. Mulvey MA. Adhesin and emtery of uropathogenic Escherichia Coli. Cell imicrobiol 2002;4(5):257-71
14. Bahrani-Mougeot FK, Buckles EL, Lockatell CV et al. Type I fimbriae and extracellular polysaccharides are pre eminent uropathogenic Escherichia coli virulence determinants in murine urinary tract. Mol Microbiol 2002;45(4):1079-93.
15. Dodson KW. Pinkner JS. Rose T et al. Structural basis of interaction of pyelonephritic E-coli adhesion to its human kidney receptor cell 2001;105:733-43.
16. Ramos HC, Rumbo M, sirard JC. Bacterial flagellins: Mediators of pathogenicity and host immun responses in mucosa. Trends imicrobiol 2004;12(11):509-17
17. Allison C, Emody L, coleman N et al. the role of swarm cell differentiation and multicellular migration in the uropathogenicity of proteus mirabilis J infect Dis 1994; 169(5):1155-8
18. Jacobson SH, Tullus K, Wretlind B et al. Aerobactin- mediated uptake of iron by strains of Escherichia coli causing acute pyelonephritis and bacteremia J infect 1988;16(2):147-52
19. Trantner BW, Darouiche Ro. Role of Biofilm in catheter-associated urinary tract infection. Am J infect control 2004;32(3):177-83.
20. Alexander C, Rietschel ET, Bacterial Lipopolysaccharides and innate immunity. J Endotoxin Res 2001; 7(3):167-202.
21. Dwyer, Peter L. a, O Reilly, Mary b. Recurrent urinary tract infection in the female, current opinion in obstetrics and gynaecology. 2002; 14(5):537-43.
22. Thornhill JA, Fitzpatrick JM urinary tract infection in: Stanton SL, Monga AK clinical urogynaecology 2nd ed, London: Churchill living stone. 2000:339-40.
23. Sbanborg C Resistance to urinary tract infection NEJM 1993; 329 (11): 802-03.
24. Tanagho EA, Mc Aninch JW. Non-specific infection of the genitourinary tract in: smith’s general urology, 14th ed, Norwalk, Appleton & lange. 1995; 201-44
25. Eykyn SJ urinary tract infection in the elderly. British Journal of urology 1998;82(1):79-84
26. Stamey TA: Pathogenesis and treatment of urinary of urinary tract infections. Williams and Wilpins company Blatimore, 1980.
27. Stamey TA Fair WR, Timothy MM et al. serum versus urinary antimicrobial concentrations in cure of urinary tract infections. New Eng Journal of Med 291:1159,1974
28. Brun-Buisson C, Legrand P, Philippon-A et al. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant klebsiella pneumonia lancet1987; (2):302-6
29. Iravani A Advances in the understanding and treatment of urinary tract infection in young women urology 1991;37:503.
30. Hooton TM, Stamm WE: Management of acute uncomplicated urinary tract infection in adults. Medical clinics of North America 1991; 75:339.
31. Barza M. et al. Single or multiple daily doses of aminoglycoside: A meta analysis British Medical Journal, 1996;321(7027):338-45.
32. Naber KG, Fluoroquinolones in urinary tract infection proper and improper use. Drugs 50 (supple 2) PP 27-33-1996
33. Wright AJ, Walker RC, Barret DM. The flouroquinolones and their appropriate use in treatment of genitourinary tract infections AUA update series, Ball TP, Novicki DE, Editor American Urologic Association, Houston, PP 1993; 50-55.
34. Johnson JR, Lyons MF, Pearce W. Therapy for women hospitalized with acute pyelonephritis, A randomized trial of Ampicillin versus trimethoprim, sulfamethaxazole for 14 days. Journal of infectious diseases. 1991; 163-325.
35. Tariq KM, Shah S. Humayun experience with gram negative bacilli isolated from 400 cases of urinary tract infections. J Ayub Med coll Abbottabad 2000; 12(4):21-23.
36. Snell RS. The Abdomen part II, The Abdominal cavity clinical anatomy by regions. 8th ed. Philadelphia: Lippincott Willims & Wilkins. 2008;260-357.
37. Chaurasia BD. The urinary bladder and the urethra. Human Anatomy: Regional and applied dissection and clinical vol 2nd, 4ed ed. New Delhi: CBS publishers & distributors 2004;345-51.
38. R Orenstein E.S, Wong. Urinary tract infection in adults. American family physician.1999.
39. Stull TL, Li Puma PJ. Epidemiology and natural Story of urinary tract infection in children. Med Clin North Am 1991; tract infections in a tertiary care hospital. Pak J Med Sci. 2014;30(2):389-92

Most read articles by the same author(s)